Schwabe Group is a group of companies in the pharmaceutical and healthcare sector. Across all its member companies, plants form the basis for the development of medicines and health products. The group generates total revenues of approximately €950 million. Founded in Leipzig in 1866, the group has been globally active for 160 years and today employs around 4,000 people worldwide, of whom approximately 1,400 are based in Germany. The group is headquartered in Karlsruhe.
Synaptikon GmbH was founded in Berlin in 2011 and develops digital solutions to promote cognitive health. With over 30 million users worldwide, the company is one of the leading providers of digital cognitive interventions. The app NeuroNation MED is permanently approved as a Digital Health Application (DiGA) and can be prescribed by physicians and psychotherapists. NeuroNation MED is available in German and English and is continuously developed in collaboration with research institutions such as Charité Berlin, University Hospital Jena and the University of Cologne.
Both companies share the common goal of helping people maintain their cognitive health as long as possible through scientifically grounded solutions. Long-term, they aim to develop disease-modifying therapies combining cognitive training, physical activity, nutrition and pharmacological support, made accessible worldwide through personalized digital formats.
“We are a very strong strategic and cultural fit. We are convinced that by combining pharmaceuticals with digital solutions, we can create meaningful synergy for patients and grow together as strong partners.” – Olaf Schwabe, CEO, Schwabe Group
“The Carlsquare team helped us tremendously to get the transaction over the line and pave the way for a good start of an exciting future together with NeuroNation.”– Dr. Isabel Freund, Senior Manager Global Business Development, Schwabe Group
“Through this partnership, we gain a long-term oriented partner who shares our passion for digital innovation in healthcare. Together, we will accelerate NeuroNation’s international expansion and set new standards in digital healthcare.” – Rojahn Ahmadi, Co-Founder & Managing Director, Synaptikon GmbH
Carlsquare acted as the exclusive adviser to Schwabe Group on this transaction.
